Key stats
About VANECK BIONIC UCITS ETF
Expense ratio
0.55%
Home page
Inception date
Dec 2, 2022
ISIN
IE0005TF96I9
Functions as an open-end investment fund
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.81%
Health Technology94.84%
Distribution Services2.68%
Electronic Technology2.29%
Bonds, Cash & Other0.19%
Cash0.19%
Stock breakdown by region
North America81.15%
Europe14.29%
Oceania4.36%
Asia0.21%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings
Dividends
Dividend payout history